December 1993
Volume 34, Issue 13
Free
Articles  |   December 1993
Differential expression of the complement regulatory proteins in the human eye.
Author Affiliations
  • N S Bora
    Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • C L Gobleman
    Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • J P Atkinson
    Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • J S Pepose
    Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • H J Kaplan
    Department of Ophthalmology, Washington University School of Medicine, St. Louis, Missouri 63110.
Investigative Ophthalmology & Visual Science December 1993, Vol.34, 3579-3584. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N S Bora, C L Gobleman, J P Atkinson, J S Pepose, H J Kaplan; Differential expression of the complement regulatory proteins in the human eye.. Invest. Ophthalmol. Vis. Sci. 1993;34(13):3579-3584.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
This content is PDF only. Please click on the PDF icon to access.
Abstract

PURPOSE: The presence of complement activation products in the human eye during infection or inflammation has been well described. During complement activation the host must be protected from attack against self tissue; this is achieved by three membrane-bound complement regulatory proteins: membrane cofactor protein (MCP, CD46), decay accelerating factor (DAF, CD55), and membrane attack complex inhibiting protein (CD59). This study was undertaken to analyze the expression of these proteins in the normal human eye. METHODS: Tissues were sectioned by cryostat and both polyclonal and monoclonal antibodies to MCP, DAF, and CD59 were used. Control stains were performed with nonrelevant antibodies of the same immunoglobulin subclass and normal rabbit serum as well as by omission of the primary and secondary antibodies. RESULTS: All three proteins were found to be differentially expressed in the human eye. With anti-MCP, strong staining of the corneal epithelium and weak staining of the corneal keratocytes in stroma and photoreceptor cells was observed. Staining with anti-DAF was very strong in the corneal epithelium and the ciliary body and moderate in the corneal stroma (keratocytes) and iris. In contrast, anti-CD59 stained very strongly in the corneal epithelium, corneal stroma (keratocytes), iris, choroid, and all layers of the retina, and moderately in the ciliary body. CONCLUSIONS: Identification of MCP, DAF, and CD59 in the human eye provides evidence that a regulatory system exists to protect these cells from destruction by complement-activating events. It remains to be determined if other more specialized functions exist for these proteins, especially in the case of CD59 because of its extensive expression in the retina.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×